Mark Cuban says that Trumprx could change the operation of pharmaceutical managers: “ If that happens, Trump obtains all the credit and it will be deserved ”

The president announced on Tuesday to launch Trumprx.gov, a federal website operated by the government to sell prescription drugs directly to consumers at reduced prices. Cuban founded Cost Plus Drugs, a similar DTC platform in 2022 in order to disrupt the health care industry. The online market sells hundreds of generic drugs at reduced prices by bypassing the managers of third-party pharmacy (PBM) services which manage the prescription advantages on behalf of employers and insurance companies. These PMBs then negotiate the discounts with drug manufacturers, but often keep the money generated by these discounts.

“I think it might have an impact,” said Cuban Fortune in an email. “Their challenge will be to know who has more power and influence on industry, PBM / insurance companies and the contracts they have with brand manufacturers or president. It has not yet been determined. ”

The Trump administration is associated with Pfizer to sell business drugs at a direct cost to the consumer (DTC) of an average value of 50% savings, according to the pharmaceutical giant. Other drug manufacturers will join the program, according to Trump. The website will be posted at the beginning of 2026.

The partnership with the White House will allow Pfizer a three -year stay of Trump’s pharmaceutical rates, which should come into force on Wednesday, but it also marks a step forward in the “most favored” pricing approach to the president of pharmaceutical products. Trump signed a decree in May in order to align the price of American drugs with those of other countries.

Americans pay much more for prescription drugs than patients from other countries. In 2022, the prices of drugs for generic and brand medicines were 2.78 times higher than those of other OECD countries, according to government data.

Cuban’s point of view on Trumprx

Cuban gave the Trumprx platform a note from a “B”, he said on Tuesday on social networks, giving the Trump Administration Credit for calling “big people” for the project, such as Chris Klump, director of Medicare and Deputy Administrator of Centers for Medicare & Medicaid services in the Ministry of Health and Social Services.

The venture capital said that the platform would have won an “A”, but that the PBMS shares prices, such as Optumrx’s parent company, Unitedhealth Group, checked after the announcement, indicating that companies do not believe that the new platform will make a big difference at that time, said Cuban. According to the investor, Trump’s platform always has the possibility of making waves.

“He is always rigged in favor of large PBMs,” said Cuban on X. “That said. He has a chance if they force PBM to change. If that happens, Trump gets all the credit and he will be deserved.”

Cuban says Fortune PBMS “Game the System” by making the basis of the price of brands based on the discounts. A New York Times The survey in 2024 revealed that, although PBM has the capacity to reduce the costs of consumer medicines by negotiating with pharmaceutical companies, which consumers are able to pay by insurance, many have more dear to more expensive drugs and earned billions of dollars by creating subsidiaries to perceive costs of drug manufacturers.

“So, until these fundamental problems change, it will be difficult to really have an impact on prices for all patients,” said Cuban.

However, public health experts are skeptical about DTC medication platforms, which has a significant impact on more affordable health care, especially since Trumprx is currently applied to Pfizer, said Drew Altman, President and Chef Nbc. Since DTC platforms have removed PBM, they become de facto cash pharmacies that cannot accept insurance plans, which can benefit from savings.

“Most Americans buy drugs thanks to their insurance scheme, which would mainly help unnsured,” said Altman.

Global Forum fortune returns on October 26 to 27, 2025 in Riyadh. CEOs and world leaders will meet for a dynamic event only invitation that shapes the future of business. Request an invitation.